Table 2.

Safety evaluation of plasma treatment among two CAP‐treated groups and control group

	Control group	90s’ treatment	180s’ treatment	P
WBC (×1012/L)	9466.7 ± 1282.9	8883.3 ± 485.6	9400.0 ± 576.6	NS
ALT (U/L)	8.3 ± 2.3	9.3 ± 3.5	8.67 ± 5.03	NS
AST (U/L)	115.33 ± 75.38	184.0 ± 29.5	71.0 ± 44.7	NS
BUN (mmol/L)	1.4 ± 0.7	2.5 (1.3, 4.7)	6.10 ± 3.6	NS
Cr (mg/dL)	1.7 ± 0.7	1.7 ± 0.6	1.5 ± 0.6	NS

Note: Continuous data are presented as mean ± SD, or median (5th‐95th percentile) as appropriate.

Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; WBC, white blood cell.